NASDAQ: PMDPsychemedics Corp Stock Ownership - Who owns Psychemedics?
Insider buying vs selling
Have Psychemedics Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Charles M. Doucot | Executive Vice President | 2023-08-17 | 12,700 | $4.66 | $59.18kSell |
| Raymond C. Kubacki Jr. | Chairman CEO President | 2023-05-22 | 1,500 | $4.93 | $7.40kSell |
| Michael I. Schaffer | VP of Laboratory Operations | 2023-05-22 | 375 | $4.93 | $1.85kSell |
| Charles M. Doucot | Executive Vice President | 2023-05-22 | 825 | $4.93 | $4.07kSell |
| Raymond C. Kubacki Jr. | Chairman CEO President | 2023-05-15 | 1,725 | $4.87 | $8.40kSell |
| Charles M. Doucot | Executive Vice President | 2023-05-15 | 900 | $4.87 | $4.38kSell |
| Michael I. Schaffer | VP of Laboratory Operations | 2023-05-15 | 337 | $4.87 | $1.64kSell |
PMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PMD insiders and whales buy or sell their stock.
PMD Shareholders
What type of owners hold Psychemedics Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Peter Kamin | 17.41% | 999,997 | $2.56M | Insider |
| H. Wayne Huizenga | 8.43% | 484,196 | $1.24M | Insider |
| Richard T. Christoph | 6.91% | 397,100 | $1.02M | Insider |
| Fred J. Weinert | 5.14% | 294,945 | $755.06k | Insider |
| 22nw LP | 4.78% | 274,418 | $702.51k | Institution |
| Renaissance Technologies LLC | 4.62% | 265,563 | $679.84k | Institution |
| Vanguard Group Inc | 4.38% | 251,283 | $643.28k | Institution |
| Raymond C. Kubacki Jr. | 4.30% | 246,737 | $631.65k | Insider |
| Rbf Capital LLC | 2.48% | 142,142 | $363.88k | Institution |
| Harry F. Connick Sr. | 1.57% | 90,112 | $230.69k | Insider |
PMD vs Diagnostic & Research Stocks
Psychemedics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.